We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Targets ‘Illegal Rebates’ by Drugmakers, Alleged Bribes to PBMs
FTC Targets ‘Illegal Rebates’ by Drugmakers, Alleged Bribes to PBMs
The Federal Trade Commission (FTC) has warned drugmakers and pharmacy benefit managers (PBM) that it will be stepping up enforcement of alleged illegal bribes and rebates that hinder patient access to cheaper drugs.